Cost Effectiveness of Inhaled Fluticasone Propionate vs Inhaled Triamcinolone Acetonide in the Treatment of Persistent Asthma

Author： Stanford R.H.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.20, Iss.4, 2000-10, pp. : 237-244

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fluticasone propionate: a potent inhaled corticosteroid for the treatment of asthma

By Staresinic A.G.   Sorkness C.A.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 6, 2000-09 ,pp. : 1227-1244

Informa Healthcare

Access to resources Recommend Favorite

Cost Effectiveness of Fluticasone Propionate Plus Salmeterol Versus Fluticasone Propionate Plus Montelukast in the Treatment of Persistent Asthma

By Richard D. O’Connor  

PharmacoEconomics, Vol. 22, Iss. 12, 2004-01 ,pp. : 815-825

Adis International

Access to resources Recommend Favorite

Inhaled Salmeterol/Fluticasone Propionate Combination: A Review of its Use in Persistent Asthma

By Markham A.   Jarvis B.  

Drugs, Vol. 60, Iss. 5, 2000-11 ,pp. : 1207-1233

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Comparison of Salmeterol/Fluticasone Propionate versus Montelukast in the Treatment of Adults with Persistent Asthma

By Sheth K.  

PharmacoEconomics, Vol. 20, Iss. 13, 2002-01 ,pp. : 909-918

Adis International

Access to resources Recommend Favorite

Inhaled Triamcinolone Acetonide HFA 450µg Twice Daily Compared with Beclomethasone Dipropionate CFC 500µg Twice Daily in Adults with Moderate Persistent Asthma

By Hardy P.  

Clinical Drug Investigation, Vol. 20, Iss. 1, 2000-07 ,pp. : 9-17

Adis International

Access to resources Recommend Favorite